Papatsonis Dimitrios N M, van Geijn Herman P, Bleker Otto P, Ader Herman J, Dekker Gustaaf A
Department of Obstetrics and Gynecology, Free University Hospital, Amsterdam, The Netherlands.
Eur J Obstet Gynecol Reprod Biol. 2004 Jan 15;112(1):43-8. doi: 10.1016/s0301-2115(03)00272-0.
The aim of this study is to identify a subset of women presenting with preterm labor not responding upon tocolytic therapy, eventually resulting in preterm birth.
The maternal admission characteristics of 185 women with preterm labor receiving tocolysis were analysed for risk factors that could predict which women will deliver within 48 h after the start of tocolysis, or before 34 weeks gestation. Univariate analysis and multivariate logistic regression analysis was performed.
Logistic regression analysis identified the following risk factors for delivery within 48 h after the start of tocolysis: cervical dilatation at admission (odds ratio (OR, cm(-1)) 1.47; 95% confidence interval (CI), 1.44-1.49), elevated leukocyte count at admission (per 10(3) leukocytes/mm(3)) (OR 1.27; 95% CI, 1.26-1.28), use of nifedipine (OR 0.49; 95% CI, 0.26-0.49), and developing signs suggestive of chorioamnionitis following admission (OR 2.12; 95% CI, 1.04-4.33). For delivery before 34 weeks of gestation the following risk factors were identified: use of steroids (OR 5.87; 95% CI, 2.34-14.7), use of nifedipine (OR 0.46; 95% CI, 0.27-0.85), developing signs suggestive of chorioamnionitis following admission (OR 10.6; 95% CI, 3.1-35.9), and preterm premature rupture of the membranes (OR 12; 95% CI, 4.1-35.2).
Risk factors associated for delivery within 48 h after starting tocolysis are: cervical dilatation at admission, elevated leukocyte count at admission, and developing signs suggestive of chorioamnionitis following admission. Use of nifedipine was associated with a delay of delivery >48 h. Risk factors associated for delivery within 34 weeks gestation are: use of steroids, developing signs suggestive of chorioamnionitis following admission, and ruptured membranes. Use of nifedipine was associated with a delay >34 weeks.
本研究旨在确定一组接受宫缩抑制剂治疗但无反应、最终导致早产的早产女性。
分析了185名接受宫缩抑制剂治疗的早产女性的母亲入院特征,以寻找可预测哪些女性将在宫缩抑制剂治疗开始后48小时内分娩或在妊娠34周前分娩的危险因素。进行了单因素分析和多因素逻辑回归分析。
逻辑回归分析确定了宫缩抑制剂治疗开始后48小时内分娩的以下危险因素:入院时宫颈扩张(比值比(OR,cm⁻¹)1.47;95%置信区间(CI),1.44 - 1.49)、入院时白细胞计数升高(每10³白细胞/mm³)(OR 1.27;95%CI,1.26 - 1.28)、使用硝苯地平(OR 0.49;95%CI,0.26 - 0.49)以及入院后出现绒毛膜羊膜炎体征(OR 2.12;95%CI,1.04 - 4.33)。对于妊娠34周前分娩,确定了以下危险因素:使用类固醇(OR 5.87;95%CI,2.34 - 14.7)、使用硝苯地平(OR 0.46;95%CI,0.27 - 0.85)、入院后出现绒毛膜羊膜炎体征(OR 10.6;95%CI,3.1 - 35.9)以及胎膜早破(OR 12;95%CI,4.1 - 35.2)。
宫缩抑制剂治疗开始后48小时内分娩相关的危险因素为:入院时宫颈扩张、入院时白细胞计数升高以及入院后出现绒毛膜羊膜炎体征。使用硝苯地平与分娩延迟>48小时相关。妊娠34周内分娩相关的危险因素为:使用类固醇、入院后出现绒毛膜羊膜炎体征以及胎膜破裂。使用硝苯地平与延迟>34周相关。